Medication info

Coritef Powder

Prescription medicationOralApproval withdrawn
Ingredient · strength
Polyethylene Glycol 3350›52.5gSodium Chloride›1.4gPotassium Chloride›0.185gSodium Bicarbonate›0.715g
Manufacturer / importer
Taejun Pharmaceutical Co., Ltd.
Appearance
A colorless to white powder in a plastic container or a colorless to white powder in a pouch
Packaging
2L: 1 pouch (55.17g) x 4 pouches/carton, 4L: 1 pouch (55.17g) x 8 pouches/carton
Approval status
Approval withdrawn

MFDS item code 200403095 · Notified 2004.11.05

This product's status changed to Approval withdrawn on 2025.04.14. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Bowel cleansing before colon examinations and abdominal surgery
Who takes it
Adults · Children
Adult dose
(Bottle package) When using, add an appropriate amount of water to the powder in the container and dissolve it first. Add more water to the 4 L mark, shake well until the entire solution is homogeneous, and then take it. To facilitate dissolution, it may be dissolved in lukewarm water. Cooling the solution before administration improves its taste. (Sachet package) When using, place the powder from 1 sachet in a container and add an appropriate amount of water to dissolve it first. Add more water to the 500mL mark, shake well until the entire solution is homogeneous, and then take it. Take a total of 8 sachets. To facilitate dissolution, it may be dissolved in lukewarm water. Cooling the solution before administration improves its taste. This drug solution is usually administered orally, but it may be administered through a nasogastric tube if oral administration is difficult or the patient does not wish to take it orally. It is preferable to fast starting 3∼4 hours before administration of this drug, and under no circumstances should solid food be eaten starting 2 hours before administration. 1. Oral administration Adults should rapidly drink 250 mL of this drug solution every 10 minutes, rather than sipping it slowly, and continue until rectal effluent is clear or until the entire 4 L has been consumed. 2. Administration through a nasogastric tube In adults, administer at a rate of 20∼30 mL per minute (1.2∼1.8 L/hour) until rectal effluent is clear. The first bowel movement occurs approximately 1 hour after administration of this drug. There are several ways to administer this drug. For example, for patients whose examination is scheduled for later in the morning, the examination may be performed after they drink this drug solution over 3 hours, followed by an additional 1 hour to completely empty the bowel and ensure that all effluent has been passed from the colon. Alternatively (particularly for a barium enema examination), this drug solution may be administered on the evening before the examination.
Child dose
Children aged 3 years and older take 25 mL/kg body weight of this drug solution per hour until rectal effluent is clear. Cooling the solution before administration is not recommended. Children aged 3 years and older are administered this drug at a rate of 25 mL/kg body weight per hour until rectal effluent is clear. Cooling the solution before administration is not recommended.

Ingredients

Manufacturer
Taejun Pharmaceutical Co., Ltd.

Efficacy & effects

Bowel cleansing before colon examinations and abdominal surgery

View approved original text

This medication is used as a pre-treatment laxative to cleanse the colon before colonoscopy, colon X-ray examinations, and abdominal surgery. It is applicable to adult patients and helps facilitate the smooth progression of examinations or surgeries. Its function of effectively emptying the colon contributes to the accuracy of examination results. This pre-treatment process enhances the comfort and safety of the patient. Therefore, it is used for preparation before colonoscopy and related examinations.

How to take

Adult dose

(Bottle package) When using, add an appropriate amount of water to the powder in the container and dissolve it first. Add more water to the 4 L mark, shake well until the entire solution is homogeneous, and then take it. To facilitate dissolution, it may be dissolved in lukewarm water. Cooling the solution before administration improves its taste. (Sachet package) When using, place the powder from 1 sachet in a container and add an appropriate amount of water to dissolve it first. Add more water to the 500mL mark, shake well until the entire solution is homogeneous, and then take it. Take a total of 8 sachets. To facilitate dissolution, it may be dissolved in lukewarm water. Cooling the solution before administration improves its taste. This drug solution is usually administered orally, but it may be administered through a nasogastric tube if oral administration is difficult or the patient does not wish to take it orally. It is preferable to fast starting 3∼4 hours before administration of this drug, and under no circumstances should solid food be eaten starting 2 hours before administration. 1. Oral administration Adults should rapidly drink 250 mL of this drug solution every 10 minutes, rather than sipping it slowly, and continue until rectal effluent is clear or until the entire 4 L has been consumed. 2. Administration through a nasogastric tube In adults, administer at a rate of 20∼30 mL per minute (1.2∼1.8 L/hour) until rectal effluent is clear. The first bowel movement occurs approximately 1 hour after administration of this drug. There are several ways to administer this drug. For example, for patients whose examination is scheduled for later in the morning, the examination may be performed after they drink this drug solution over 3 hours, followed by an additional 1 hour to completely empty the bowel and ensure that all effluent has been passed from the colon. Alternatively (particularly for a barium enema examination), this drug solution may be administered on the evening before the examination.

Child dose

Children aged 3 years and older take 25 mL/kg body weight of this drug solution per hour until rectal effluent is clear. Cooling the solution before administration is not recommended. Children aged 3 years and older are administered this drug at a rate of 25 mL/kg body weight per hour until rectal effluent is clear. Cooling the solution before administration is not recommended.

Precautions

This drug should not be used in patients with known allergies to this drug or its components. It should not be administered to patients with or suspected of having gastrointestinal obstruction or perforation. It is advisable to avoid administering this medication to patients who are dehydrated or have severe heart failure. Patients with colonic diseases such as toxic colitis or toxic megacolon, or patients with atrophy should not use this drug. Caution should be exercised when using it in patients with intestinal obstruction or severe constipation, elderly or frail patients. Close attention is required in patients with issues related to the gag reflex or altered consciousness, or patients receiving administration through a nasogastric tube, as there is a risk of aspiration of the medication into the lungs. Patients with severe abdominal distention or abdominal pain, as well as patients with severe ulcerative colitis, should use this drug cautiously. Rarely, allergic reactions may occur upon using this drug, so symptoms should be observed closely and treated immediately if necessary. Serious side effects such as intestinal perforation, obstruction, or strangulated hernia may occur, necessitating careful monitoring of abdominal conditions. Patients over 60 years of age should be particularly cautious as serious side effects such as gastric mucosal damage, esophageal perforation, cardiac asystole, and pulmonary edema have been reported. The most common side effects are nausea and abdominal distention, and vomiting, abdominal cramps, and anal irritation may also occur, but most are temporary. Hypersensitive reactions such as urticaria, nasal discharge, or dermatitis may manifest as well. There have been reports of increased or irregular heartbeats, elevated blood pressure, edema, and other cardiac issues, so caution is warranted. If significant abdominal pain or bloating occurs, the rate of administration should be slowed or paused, and a medical examination should be sought. If symptoms of fluid or electrolyte imbalance appear, a blood test should be conducted to assess the condition and appropriate treatment should be administered. Patients with impaired kidney function or at risk of electrolyte imbalance should undergo regular kidney function and ECG tests. For patients at high risk of heart disease, it is prudent to consider pre- and post-treatment ECG testing. This drug may induce diarrhea, so adequate hydration is essential. Coadministration with irritating laxatives should be avoided due to increased risk of colonic mucosal damage. Pregnant or breastfeeding women should only use this drug under medical supervision when absolutely necessary, as its safety has not been established. Safety has not been confirmed for children under 3 years, and careful monitoring for symptoms of hypoglycemia or dehydration is advised. Elderly patients should be administered with special care and gradually. In case of overdose, severe diarrhea may occur, necessitating symptomatic treatment such as hydration. Do not mix with other ingredients or fragrances before administration, and the solution should be used within 48 hours of preparation; any leftovers should be discarded. This drug should be stored out of the reach of children and care must be taken to not transfer it to other containers.

Side effects

Anaphylactic reactions, intestinal perforation, intestinal obstruction, incarcerated hernia, gastric mucosal damage, esophageal perforation, cardiac asystole, sudden dyspnea associated with pulmonary edema, findings of pulmonary aspiration, nausea, abdominal distension, vomiting, abdominal cramps, anal irritation, urticaria, rhinorrhea, dermatitis, tachycardia, palpitations, hypertension, arrhythmia, atrial fibrillation, peripheral edema, acute pulmonary edema, syncope, dehydration, upper gastrointestinal bleeding due to Mallory-Weiss tear, rash, pruritus, lip swelling, tongue swelling, facial swelling, dyspnea, chest tightness, throat tightness, tremors, seizures, renal dysfunction, renal failure, hypoglycemia, signs of dehydration, hypokalemia, diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly sealed container to avoid exposure to air or moisture, preferably at room temperature between 1 to 30 degrees Celsius. By storing it this way, the drug's effectiveness can be maintained for a longer period.

Appearance and packaging

Appearance

A colorless to white powder in a plastic container or a colorless to white powder in a pouch

Package unit

2L: 1 pouch (55.17g) x 4 pouches/carton, 4L: 1 pouch (55.17g) x 8 pouches/carton

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.